Atlanta
,
USA
27 - 30 September 2024
Heart Failure Society of America (HFSA 2024)
Presentation schedule and materials
Saturday, 28 September 2024
16:00
- 16:30
EDT
210
POSTER
Temporal trends in the incidence and prevalence of transthyretin amyloid cardiomyopathy in the USA: an observational database study
Kevin M Alexander1; Noel R Dasgupta2; Jimmi Mathisen3; Sidsel Høier Gamborg Møller3; Anders Tvistholm3; Mathew S Maurer4
MATERIALS AVAILABLE
Sunday, 29 September 2024
09:00
- 10:30
EDT
2364
ORAL PRESENTATION
Efficacy of Semaglutide in Patients With Obesity and HFpEF According to Frailty Status: A Pooled Analysis from the STEP-HFpEF Program
Ambarish Pandey1; Dalane W. Kitzman2; Barry A. Borlaug3; Javed Butler4; Melanie J. Davies5; Sanjiv J. Shah6; Subodh Verma7; Mark C. Petrie8; Cecilia Rönnbäck9; Anne Domdey9; Karoline Liisberg9; Morten Schou10; Eduardo Perna11; Fozia Z. Ahmed12; Michael Fu13; Khaja M. Chinnakondepalli14; Shachi Patel14; Mikhail N. Kosiborod15
MATERIALS AVAILABLE
09:00
- 10:30
EDT
2321
ORAL PRESENTATION
Semaglutide and exercise function in obesity-related HFpEF: Insights from the STEP-HFpEF Program
Barry A. Borlaug1; Dalane W. Kitzman2; Shachi Patel3; Khaja M. Chinnakondepalli3; Javed Butler4; Melanie J. Davies5; Mark C. Petrie6; Sanjiv J. Shah7; Subodh Verma8; Julio Núñez9; Mette Nygaard Einfeldt10; Karoline Liisberg10; Afshin Salsali10; Mikhail N. Kosiborod11; for the STEP-HFpEF Trial Committees and Investigators
MATERIALS AVAILABLE
Keywords